Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
about
Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Erratum: Once daily administra ...... minuria in diabetic db/db mice
@en
Erratum: Once daily administra ...... inuria in diabetic db/db mice.
@nl
type
label
Erratum: Once daily administra ...... minuria in diabetic db/db mice
@en
Erratum: Once daily administra ...... inuria in diabetic db/db mice.
@nl
prefLabel
Erratum: Once daily administra ...... minuria in diabetic db/db mice
@en
Erratum: Once daily administra ...... inuria in diabetic db/db mice.
@nl
P2093
P356
P1433
P1476
Erratum: Once daily administra ...... minuria in diabetic db/db mice
@en
P2093
Amelia K Fotheringham
Ben M Harvie
Carol Pollock
Danielle J Borg
Domenica A McCarthy
Hermann Koepsell
Linda A Gallo
Micheal S Ward
Nicole B Flemming
Shang-Ming Yeh
P2888
P356
10.1038/SREP28124
P407
P577
2016-07-07T00:00:00Z